The largest database of trusted experimental protocols

5 protocols using essential 8 flex media

1

Generating Isogenic iPSC Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
GBA1 N409S heterozygous PD patient-derived iPSCs (NH50187, MUTANT) and their isogenic control cells (NH50186, ISOGENIC) were obtained from the Rutgers University Cell and DNA Repository (RUCDR). Normal karyotypes of NH50187 and NH50186 were confirmed by RUCDR. Genotypes, pluripotency, and mycoplasma infection were routinely assessed before starting new experiments (Supplementary Figure S2a,b). Undifferentiated iPSCs were grown on Laminin 521 (Biolamina, Stockholm, Sweden, LN521)-coated plates and maintained in Essential 8 Flex media (Thermo Fisher Scientific, Waltham, MA, USA, A2858501) at 37 °C, 5% CO2 until starting differentiation.
+ Open protocol
+ Expand
2

Forebrain Organoid Generation from hPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Forebrain organoids were generated from hPSCs following the protocol described in (Zhou et al., 2017 (link)). Briefly, hPSCs were dissociated into single cells using Accutase (#A11105–01, Thermo Fisher Scientific) for 30 minutes at 37°C. Afterwards, cells were aggregated using low-adhesion V-bottom plates (#MS-9096V, Wako) in Essential 8 Flex media (#A28558501, Thermo Fisher Scientific) with 10 μM ROCK inhibitor (Y-27632, #1254, Tocris) (day-1). At day0, media was changed to Essential 6 medium (E6, #A1516401, Thermo Fisher Scientific) in the presence of 500 nM LDN193189 (#04–0074, Stemgent) and 2mM XAV-939 (#3748, Tocris) until day 4. XAV-939 was removed from day 4 till day 18. Afterwards, organoids were maintained in organoid differentiation medium (50% DMEM F-12 (#11320–033, Thermo Fisher Scientific), 50% Neurobasal media (#21103–049, Thermo Fisher Scientific), 0.5xN2 supplement (#17502–048, Thermo Fisher Scientific), 0.025% insulin (#I-034, Sigma), 5 mM L-Glutamine (#25030–024, Thermo Fisher Scientific), 0.7 mM MEM-NEAA (#11140050, Thermo Fisher Scientific), 50 U/mL Penicillin-Streptomycin (#15140–122, Thermo Fisher Scientific), 55 mM 2-mercaptoethanol (#21985–023, Thermo Fisher Scientific), 1xB27 supplement - Vitamin A (#12587010, Thermo Fisher Scientific).
+ Open protocol
+ Expand
3

Cultivation and Characterization of iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
IPSCs and WA09 (H9) cells were cultured on feeder-free substrate vitronectin (Thermofisher) with Essential 8 Flex media (ThermoFisher) or mTeSR and Matrigel. Cells were passaged 1:18-1:24 every 5–7 days using ReLeSR (Stem Cell Technologies). Pluripotency was confirmed via immunostaining for TRA-1-60 (1:100, ThermoFisher), NANOG (1:200, Cell Signaling Technologies), and OCT4A (1:400, Cell Signaling Technologies). Cells were utilized between passage 18 and 50, and outgrowth analysis confirmed the conservation of neuronal outgrowth phenotypes between early and late passages (Supplementary Fig. 4B).
+ Open protocol
+ Expand
4

hPSC Maintenance and Authentication

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human pluripotent stem cells (hPSCs) (H9 derivatives (H9-CRISPRa, H9-CRISPRi, H9-CRISPRa-control, H9-CRISPRa-HERV-K(HML-2), H9-CRISPRi-control, H9-CRISPRi-HERV-K(HML-2), H9-TRE-CRISPRa-control, H9-TRE-CRISPRa-HERV-K(HML-2), H9-CRISPRa-CLSTN2, H9-CRISPRa-CHRDL1, H9-CRISPRa-EPHA4 and H9-CRISPRa-NTRK3)) were maintained with Essential 8 Flex media (#A28558501, Thermo Fisher Scientific) in feeder-free conditions on vitronectin (VTN-N) substrate (#A14700, Thermo Fisher Scientific). hPSCs were passaged as clumps with 0.5M EDTA (0.5M EDTA+ 5M NaCl+ 1X PBS). The pluripotency levels of the cells in culture was routinely authenticated for markers Nanog and Oct-4 and checked for mycoplasma contamination.
+ Open protocol
+ Expand
5

Fluctuation Analysis of Bu-1 Loss

Check if the same lab product or an alternative is used in the 5 most similar protocols
DT40 cell culture, cell survival assays, fluctuation analysis for generation of Bu‐1 loss variants (Fig EV1), and genetic manipulation of the BU‐1 locus were performed as previously described (Simpson & Sale, 2003, 2006; Schiavone et al, 2014). Drosophila S2 cells were grown in Insect‐XPRESS Protein‐Free Insect Cell Medium with l‐glutamine (Lonza), supplemented with 1% penicillin–streptomycin at 27°C, ambient CO2 with 105 rpm agitation. BOBSC human induced pluripotent stem (hiPS) cells (Yusa et al, 2011) were cultured feeder‐free on dishes coated with Vitronectin XF (07180; Stem Cell Technologies) in Essential 8 Flex media (A2858501; Thermo Fisher Scientific) at 37°C and 5% CO2. Cells were split 1:10–1:15 every 3–4 days depending on confluence. All cells tested negative for mycoplasma.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!